The past two decades have produced more changes in therapeutic methods and technique than were seen during the previous history of psychiatry. Not only have powerful drugs which result in dramatic control of symptoms been available, but new techniques have been introduced which differ markedly from the medical model and from individual psychotherapy. A limited number of these new techniques are discussed in this symposium. Many would appear to be varying terms for fundamentally similar approaches; others are old techniques under new names; while a few represent entirely new concepts and philosophies. All introduce fundamental problems in evaluation which make it difficult to choose the therapy most helpful to the patient, in keeping with current and anticipated facilities. It is also difficult to objectively evaluate these new methods.
The time-honoured method of evaluation of any treatment is simple and directa physician discovers a new treatment which he believes will help in a certain type of illness, and on the basis of his clinical observation decides that the patient has responded more completely and quickly to this approach than to previous treatment techniques. In a very limited set of circumstances this is still adequate. The efficacy of penicillin in many infections and the value of major tranquillizers in the control of psychotic symptoms was obvious to the most casual observer. It still must be the starting point in any new treatment but in most instances in psychiatry true evaluation must involve more subtle techniques due to the great variation in. the type of patients, the spontaneous changes in many illnesses, the influence of environmental factors beyond our control and, most signi-ficantly, the enthusiasm of the therapist which often reaches the stage of doubting the need for any evaluation beyond his own opinion.
For these .reasons, more complicated and at times apparently unnecessarily complica.ted procedures have been introduced. First of all there must be an experimental group selected which is of a uniform disorder and where the variables which may influence outcome are recognized and documented. This group must then be compared a.s to outcome with a comparable group who are not receiving treatment (usually not ethically possible) or with persons receiving a different type of treatment. These groups are carefully matched for variables which may influence the observations in either direction, by masking a real improvement or by making it appear superior when it is not so. Even in the evaluation of drugs the picture in psychiatry is not a simple one, and an example of this is the controversy regarding the efficacy of the antidepressant drugs. Most psychiatrists believe they are useful but are uncertain as to which patients they will help. Evaluation of these drugs is still a trial and error procedure influenced by experience, with a limited number of patients who responded.
Although the evaluation of many therapeutic procedures is difficult there are none which cannot be mastered. It would appear possible to set up an experimental study on a small selected group of patients with matched controls and objective evaluation by means ofa number of questionnaires which have been developed over the past few years, in an attempt to evaluate the clinical picture in an objective manner. After all, the British have produced a number of relatively clearcut objective studies on the evaluation of psychotherapy versus no psychotherapy, as well as techniques in the evaluation of non-medical behavioural therapies in a few clearly defined sub-groups of the psychoneuroses. In this issue two papers, one by Shamsie and Clark and the other by Sampath, et al., are encouraging in this respect since they have chosen a specific and fairly circumscribed problem and have made an attempt at evaluation.
Part of the difficulty in evaluating these non-medical therapies, apart from the vagueness of the problem, is the lack of adequate financing for research. In the first place the granting bodies might consider the findings vague and 'soft data'. The submission must compete with more clearcut and objective projects which in many cases are far less meaningful in their contribution to the field of psychiatry. Moreover, adequate organization for evaluation would be expensive, and granting bodies are partial to the small limited projects of short duration and of little clinical significance. To evaluate the various procedures of psychiatry requires the estabishment of fairly large research units along the lines of the Medical Research Units of Great Britain which are involved in patient care but which have sufficient time to establish worthwhile projects. This would require a complete change in the thinking of most granting bodies who are overly concerned with the X' and less concerned with the clinical significance of the studies. Up to the present time applications for clinical research, particularly those involving attempts at evaluation, are the forgotten ones.
The history of psychiatry has been marked by a procession of 'band wagons' of limited life expectancy. Unless better methods of evaluation, supported by facilities for clinical trial, are developed, this will continue to be the story of psychiatric therapies.
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